PTC Therapeutics, Inc. (PTCT)
74.10
+0.63
(+0.86%)
USD |
NASDAQ |
Dec 10, 16:00
74.60
+0.50
(+0.67%)
Pre-Market: 08:52
PTC Therapeutics Market Cap: 5.949B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Spyre Therapeutics, Inc. | 2.689B |
| Pyxis Oncology, Inc. | 267.11M |
| NovaBay Pharmaceuticals, Inc. | 304.95M |
| Palatin Technologies, Inc. | 23.82M |
| Theriva Biologics, Inc. | 7.473M |
Market Cap Related Metrics
| PE Ratio | 8.661 |
| PS Ratio | 3.424 |
| Price to Free Cash Flow | 13.65 |
| Price | 74.10 |
| Earnings Yield | 11.55% |
| Operating PE Ratio | 6.606 |
| Normalized PE Ratio | 7.498 |